Answers are grounded in this paper and cite their sources.
We show that IBC is transcriptionally heterogeneous and that all molecular subtypes described in nIBC are detectable in IBC, albeit with a different frequency. The molecular profile of IBC, bearing molecular traits of aggressive breast tumor biology, shows attenuation of TGF-β signaling, potentially explaining the metastatic potential of IBC tumor cells in an unexpected manner.
No takes yet. Share an insight, caveat, or question.
Laere et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: